company insight

Pharma Support Services Ltd  - your regulatory and pharmaco vigilance provider in Eastern Europe

Achieving compliance with local requirements can be a tough deal and an unexpected challenge sometimes -

Achieving compliance with local requirements can be a tough deal and an unexpected challenge sometimes

Hence you need a partner you can trust

Given the diversity of the Eastern European region and the fact that the languages spoken are very different from one another (as both Cyrillic and Latin alphabets are used in the region dependent on the country) launching your products can be a challenge. It needs to be matched with a local expertise in regulatory affairs, pharmacovigilance and pricing - all of which are essentials for speedy access to Eastern European markets. Whether you are only exploring possibilities to expand or already have presence in Eastern Europe we can adapt our services to be of help to your business.

As a first prerequisite we ensure you receive a well-grounded legal advice and country-specific background. Based in Sofia, Bulgaria and having reliable partners all over Eastern Europe, we can find the right partner for you should you be looking for a GMP, GDP compliant warehouse or support with medical devices and medicinal products registration and their pricing and reimbursement possibilities. As the healthcare systems in many of the countries in the region are based on the so-called „external reference pricing system“ we can provide guidance on which countries are included in the reference basket and what strategy can be adopted to secure your product on the market.  

we can find the right partner for you should you be looking for a GMP

Worried about Brexit outcome?

Further down the line of establishing in your business in Eastern Europe we are happy to support you with transfer of marketing authorisations, finalization of national phases of your DCP/MRP applications as well as start a national authorisation procedure for your product, should you be interested in one market only. We have a broad expertise in registration and communication of all necessary requirements so that you can focus on marketing your products while we do the rest.

In addition to local pharmacovigilance point of contact as well as literature screening of non-indexed journals and publications we perform follow-up assessment of relevant articles/scientific extracts. Medical review of cases published in literature can help you identify important signals concerning the safety profile of your products. And a lot of locally issued journals are not indexed by Embase and Medline, so we can provide further assistance with these issues.

Share this article

Go to article: Home | The Dawn of Big DataGo to article: EditorialGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: How will Amazon's acquisition of online pharmacy business PillPack disrupt the pharmaceutical industry? Go to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Fentanyl: where did it all go wrong?Go to article: NSFGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Turning up the heat on nano researchGo to article: TSS Company InsightGo to article: TSS ABGo to article: MedelpharmGo to article: Cracking the mystery of Alzheimer's diseaseGo to article: Röchling Medical NeuhausGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Where are the world's pharma manufacturing hotspots?Go to article: Gerteis Company InsightGo to article: GerteisGo to article: ZenatekGo to article: How India’s use of unapproved antibiotics could undermine global healthGo to article: Novo Nordisk PharmatechGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: CRISPR: a seismic shift in gene editingGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Is the UK’s drug evaluation system in need of an overhaul?Go to article: Nelson Labs Company InsightGo to article: Nelson LabsGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Opening up the Chinese drug marketGo to article: Finnair Cargo | Company InsightGo to article: Finnair CargoGo to article: Immunising against opioids – could a vaccine solve the crisis? Go to article: Molnar Company InsightGo to article: MolnarGo to article: PharmasolGo to article: The next generation of antimalarials Go to article: Oncology Therapeutic Development Company InsightGo to article: Oncology Therapeutic DevelopmentGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: G.F.Go to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: Amazon and PillPack: an unstoppable pharmacy force?Go to article: BEAGo to article: Buchi Labortechnik AG Company InsightGo to article: Buchi Labortechnik AGGo to article: Is the microbiome as important for precision medicine as genetics?Go to article: Medical HempGo to article: Senn ChemicalsGo to article: Senn ChemicalsGo to article: Niconex Medical LtdGo to article: HPV vaccines: a decade of progressGo to article: Med-Script AssociatesGo to article: B&W Tek | Company InsightGo to article: B&W TekGo to article: EventsGo to article: CG ChemikalienGo to article: AlpexGo to article: Next issueGo to article: Pall Biotech Company InsightGo to article: CrewpharmGo to article: EndocaGo to article: Diversey